Creating A New Universe Of
Genetic Medicines
Revolutions in AI, biology and automation are enabling a new approach to medicine. Deep Genomics is at the forefront.
Press

“Canada’s AI Explosion: Visit three labs where machines are being taught to think like people”
March 26, 2018

“Khosla backs AI startup creating new class of genetic drugs”
September 25, 2017

“The basic fact is no human or group of humans will ever understand how the genome works”
August 28, 2017

“The next blockbuster drug could be developed with help from machine learning techniques”
May 3, 2017
Updates
Learn about the latest developments at Deep Genomics
Discovering Therapies for Neuromuscular Disorders
April 10, 2018
Deep Genomics to collaborate with Wave Life Sciences to discover novel therapies for genetic neuromuscular disorders
Taking on Metabolic & Neurodegenerative Disorders
March 26, 2018
Deep Genomics to identify oligonucleotide candidates for treating genetically defined metabolic and neurodegenerative disorders
$13M Invested in AI Platform for Genetic Medicines
September 25, 2017
Equity investment by Khosla Ventures, True Ventures and Bloomberg Beta will be used to direct platform to drug discovery
© 2018 DEEP GENOMICS. ALL RIGHTS RESERVED.